Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Akgun; Re search & De vel op ment: Serap<br />
Tutumluer<br />
Sub sid iary of: Sandoz, Ger many (100%)<br />
NOVARTIS<br />
Full Name: Novartis Saglik, Gida ve Tarim<br />
Urunleri Sanayi ve Ticaret A.S.<br />
Street Ad dress: Barbaros Bulvari No 83,<br />
Besiktas, 34353 Is tan bul<br />
Tel: +90 212 326 91 00<br />
Fax: +90 212 236 78 43<br />
Email: novartis.tr@pharma.novartis.com<br />
Home Page: www.novartis.com.tr<br />
De scrip tion: Re searcher, man u fac turer,<br />
packager/as sem bler, im porter, ex porter, dis trib -<br />
u tor, pro moter, sales/detailer. Man u fac tures, ex -<br />
ports for other com pa nies. Prod uct ranges<br />
in clude: phar ma ceu ti cal prod ucts (branded, pre -<br />
scrip tion, non-pre scrip tion), hos pi tal<br />
pharmaceuticals, bi o log i cal prod ucts, di etetic/nu -<br />
tri tional prod ucts, op ti cal in stru ments, oph thal mic<br />
prod ucts, vet er i nary pharmaceuticals. Es tab -<br />
lished 1997. 718 phar ma ceu ti cal em ploy ees in<br />
2005. Di vi sions include: Pharma; Consumer<br />
Health; Ciba Vision; Nutrition.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 420 (2005)<br />
Con tacts (Pharm): Chair man: Altan Demirdere;<br />
Com mer cial Op er a tions: Guldem Berkman (PC &<br />
MP), Tolay Tdroz (CPH), Dilek Boke (Onc), Emre<br />
Eran (Tx); Man u fac ture: John Paul Man ning; Mar -<br />
ket Re search: Gamze Alatan; Re search & De vel -<br />
op ment: Ugur Ozkutlu; Gen eral Con tact: Kurt<br />
Gamze Alatan<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 600-620 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 45-50%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 50-55%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
GLIVEC (antineoplastic other)<br />
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -<br />
tion)<br />
FORADIL COMBI (B2-stim u lant/corticoid com bi -<br />
na tion)<br />
VOLTAREN (antirheumatic non-steroidal;<br />
antirheumatic top i cal; oph thal mic anti-in flam ma -<br />
tory non-steroidal)<br />
MIACALCIC (calcitonin)<br />
Ther a peu tic Range:<br />
renin-an gio ten sin sys tem agents 17%<br />
antineoplastics 15%<br />
antiasthma and COPD prod ucts 14%<br />
anti rheu ma tics sys temic 4%<br />
hor mones other 4%<br />
Lead ing Dose Forms:<br />
coated tab lets 51%<br />
cap sules 19%<br />
liq uids 9%<br />
tab lets 7%<br />
in fu sions 5%<br />
NOVARTIS CON SUMER HEALTH<br />
Full Name: Novartis Saglik, Gida ve Tarim<br />
Urunleri Sanayi ve Ticaret A.S.<br />
Street Ad dress: Is Kuleleri Kule-2 Kat:4, 4.<br />
Levent, 34330 Is tan bul<br />
Tel: +90 212 339 28 00<br />
Fax: +90 212 279 21 44<br />
Home Page: www.novartis.com.tr<br />
Phar ma ceu ti cal Sales: US$ 60-65 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 70-75%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 85-90%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
85-90%<br />
Prin ci pal Prod ucts:<br />
OTRIVINE (na sal prep a ra tion top i cal)<br />
SINECOD (antitussive)<br />
VENORUTON (var i cose ther apy sys temic)<br />
THERAFLU (cold prep a ra tion with out anti-in fec -<br />
tive)<br />
FENISTIL (antipruritic)<br />
Ther a peu tic Range:<br />
cough and cold prep a ra tions 32%<br />
na sal prep a ra tions 21%<br />
antivaricosis/antihemorrhoidal prep a ra tions<br />
20%<br />
antipruritics 8%<br />
CNS drugs other 7%<br />
Lead ing Dose Forms:<br />
liq uids 40%<br />
coated tab lets 19%<br />
tab lets 16%<br />
gels/sols 8%<br />
creams 7%<br />
SANDOZ<br />
Full Name: Sandoz Ilac Sanayi ve Ticaret A.S.<br />
Street Ad dress: GEPOSB Ataturk Bulvari 9.<br />
Cadde No. 1, 41400 Gebze - Kocaeli<br />
Tel: +90 216 458 33 00<br />
Fax: +90 262 751 30 36<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 216